All posts tagged "Breakthrough Therapy Designation"

• 

  370

  1

  Biotech

  Picking a Bottom in CytoDyn – Right Now

  CytoDyn Inc (OTCMKT: CYDY) has been under considerable selling pressure since April and nothing seems to be able to stop it.  In...

• 

  300

  2

  Biotech

  CytoDyn’s Preliminary Phase 1b/2 Cancer Results Likely to Receive Breakthrough Therapy Designation (BTD)

  CytoDyn Inc. (OTCMKTS: CYDY) announced excellent preliminary results from its Phase 1b/2 clinical trial in metastatic triple negative breast cancer...

• 

  425

  6

  Biotech

  Leronlimab Trial Results All But Certain Pointing to Approval For CytoDyn

  CytoDyn Inc. (OTMKTS: CYDY) announced discussions with 3 regulatory agencies after an unblinding of the data on February 22, 2021, and the...

• 

  14.5K

  1

  Biotech

  CytoDyn (OTCMKTS: CYDY) Bolts Higher On Mexican Approval Chatter

  Yesterday CytoDyn Inc. (OTCMKTS: CYDY) moved up 27% on the completion of a Memorandum of Understanding with the NIH of Mexico to...

• 

  225

  Biotech

  Investors Fleeing CytoDyn Missing the Golden Nugget from the BLA Delay

  Sell first analyze later mentality of investors oblivious to the increased likelihood of a BLA approval may cost them handsome upside CytoDyn...